Thursday broker round-up
(Sharecast News) - Diageo: Jefferies downgrades to hold with a target price of 3,600p

(Sharecast News) - Diageo: Jefferies downgrades to hold with a target price of 3,600p
(Sharecast News) - Barclays downgraded its stance on GlaxoSmithKline shares to 'underweight' from 'equalweight' on Thursday, as it said 2020 looks set to be a much tougher investment year of little growth.
UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight
LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio
* FTSE 100 up 0.3%, FTSE 250 down 0.2%* U.S. tariffs on China to remain in place for now* Tullow Oil drags midcaps lower* Banks drop on rate cut bets (Adds company news items, updates to closing prices)By Shashwat Awasthi and Muvija MJan 15 (Reuters...
Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning
FRANKFURT, Jan 6 (Reuters) - A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens of drugmakers test a record number of new com...
By Ludwig Burger and John MillerFRANKFURT/ZURICH, Jan 6 (Reuters) - Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach th...
(Refiles to fix story link in first paragraph)FRANKFURT, Jan 6 (Reuters) - A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens ...
UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons
UK Dividends Calendar - Next 7 Days
By Michael ErmanNEW YORK, Jan 1 (Reuters) - Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year's Day drug price increases to more th...
GlaxoSmithKline Completes EUR955 Million Sale Of Travel Vaccines
(Adds HPV vaccine approval in 6th and 7th paragraphs, adds background on new pneumonia case in 5th paragraph,)BEIJING, Dec 31 (Reuters) - China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its Nation...